Prolonged excretion of type-2 poliovirus from a primary immune deficient patient during the transition to a type-2 poliovirus-free world, Israel, 2016

Merav Weil*, L. M. Shulman, S. Heiman, T. Stauber, J. Alfandari, L. Weiss, I. Silberstein, V. Indenbaum, E. Mendelson, D. Sofer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Wild poliovirus type-2 has been eradicated, use of live type-2 vaccine has been terminated globally, and all type-2 polioviruses are under strict laboratory containment protocols. Re-emergence may arise from prolonged asymptomatic excretion of poliovirus by hospitalised primary immune deficient (PID) patients, as described here, through repeated exposure of close contacts to high titres of infected material. At this transition time, PID patients should be screened and hospital containment protocols updated in parallel with laboratory containment.

Original languageEnglish
JournalEurosurveillance
Volume21
Issue number47
DOIs
StatePublished - 24 Nov 2016

Fingerprint

Dive into the research topics of 'Prolonged excretion of type-2 poliovirus from a primary immune deficient patient during the transition to a type-2 poliovirus-free world, Israel, 2016'. Together they form a unique fingerprint.

Cite this